The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Subscribe To Our Newsletter & Stay Updated
